🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/04/2009 | 10,37 | 10,93 | 10,37 | 10,85 | +3,57% | 5,41% | 100.962 |
| 27/04/2009 | 10,48 | 10,78 | 10,33 | 10,48 | +0,00% | 4,29% | 74.352 |
| 24/04/2009 | 10,26 | 10,56 | 10,07 | 10,48 | +3,32% | 4,74% | 201.123 |
| 23/04/2009 | 10,48 | 10,63 | 9,96 | 10,14 | -2,87% | 6,43% | 313.867 |
| 22/04/2009 | 10,56 | 10,89 | 10,33 | 10,44 | -3,79% | 5,32% | 92.066 |
| 21/04/2009 | 10,26 | 10,97 | 10,07 | 10,85 | +5,07% | 8,76% | 213.600 |
| 20/04/2009 | 10,37 | 10,59 | 10,11 | 10,33 | -2,82% | 4,69% | 138.339 |
| 17/04/2009 | 10,74 | 10,82 | 10,48 | 10,63 | +0,00% | 3,14% | 166.712 |
| 16/04/2009 | 10,82 | 10,89 | 10,52 | 10,63 | -0,70% | 3,46% | 354.023 |
| 15/04/2009 | 10,44 | 10,89 | 10,44 | 10,70 | +1,06% | 4,30% | 151.804 |
| 14/04/2009 | 10,74 | 10,97 | 10,29 | 10,59 | -5,03% | 6,27% | 119.851 |
| 13/04/2009 | 11,45 | 11,72 | 10,93 | 11,15 | -4,49% | 6,86% | 82.848 |
| 09/04/2009 | 10,85 | 11,75 | 10,74 | 11,68 | +8,71% | 9,31% | 167.326 |
| 08/04/2009 | 10,52 | 10,85 | 10,52 | 10,74 | +2,87% | 3,20% | 68.101 |
| 07/04/2009 | 10,70 | 10,93 | 10,26 | 10,44 | -4,12% | 6,29% | 211.676 |
| 06/04/2009 | 10,97 | 11,27 | 10,78 | 10,89 | -2,68% | 4,44% | 107.668 |
| 03/04/2009 | 11,60 | 11,75 | 10,67 | 11,19 | -3,55% | 9,36% | 68.876 |
| 02/04/2009 | 11,45 | 11,83 | 10,26 | 11,60 | +3,33% | 13,73% | 263.453 |
| 01/04/2009 | 10,93 | 11,53 | 10,78 | 11,23 | +0,67% | 6,85% | 248.278 |
| 31/03/2009 | 11,27 | 11,79 | 10,44 | 11,15 | +0,34% | 11,96% | 272.483 |
| 30/03/2009 | 10,82 | 11,98 | 10,82 | 11,12 | -0,67% | 10,73% | 229.737 |
| 27/03/2009 | 11,53 | 11,75 | 11,15 | 11,19 | -5,08% | 5,19% | 187.311 |
| 26/03/2009 | 11,49 | 11,79 | 11,15 | 11,79 | +4,30% | 5,54% | 322.978 |
| 25/03/2009 | 10,85 | 11,30 | 10,44 | 11,30 | +8,63% | 7,93% | 539.463 |
| 24/03/2009 | 10,74 | 11,19 | 10,37 | 10,41 | -4,79% | 7,66% | 136.602 |
| 23/03/2009 | 10,63 | 11,00 | 10,44 | 10,93 | +6,96% | 5,28% | 150.174 |
| 20/03/2009 | 10,82 | 10,85 | 10,18 | 10,22 | -4,21% | 6,23% | 197.276 |
| 19/03/2009 | 10,82 | 10,82 | 10,52 | 10,67 | +0,71% | 2,77% | 103.046 |
| 18/03/2009 | 10,85 | 11,00 | 10,44 | 10,59 | -4,07% | 5,17% | 229.817 |
| 17/03/2009 | 10,82 | 11,04 | 10,63 | 11,04 | +2,43% | 3,81% | 156.506 |